During the past decade, Radiation Oncology Associates conducted 113 clinical trials. In the 10-year time frame, 113 clinical trials started and 34 clinical trials were completed, i.e. on average, 30.1% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 30 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiation Oncology Associates" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "Children's Oncology Group" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Radiation Oncology Associates" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (5 trials). Many other conditions were trialed in "Radiation Oncology Associates" in a lesser frequency.

Most popular intervention types in "Radiation Oncology Associates" are "Drug" (103 trials), "Other" (72 trials), "Biological" (55 trials), "Procedure" (43 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (29 trials), "Computed Tomography" (27 trials), "Biospecimen Collection" (24 trials) and "Nivolumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "Radiation Oncology Associates" are 116 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Radiation Oncology Associates". undefined are not yet recruiting, 42 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Radiation Oncology Associates, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Radiation Oncology Associates, 3 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".